Safety and Efficacy of a Drug Delivery System in Glaucoma

Completed · Phase 2 · Has a placebo group

Conditions studied: Open-angle Glaucoma, Ocular Hypertension

In brief

Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT01016691

Run by

Vistakon Pharmaceuticals

People needed

47

Starts

2009-10-01

Last updated by the study team

2015-03-06

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Man or woman 21 years of age or greater
• Open angle glaucoma or ocular hypertension
• Corrected visual acuity in each eye of 20/200 or better

You may not qualify if…

• Previous glaucoma intraocular surgery or refractive surgery
• Planned contact lens use during the study
• Clinically significant ocular or systemic disease that might interfere with the study
• Use of chronic corticosteroids by any route

Where it is running

• Study site — Miami, Florida, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Mt. Pleasant, South Carolina, United States
• Study site — Rapid City, South Dakota, United States
• Study site — Maryville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.